Showing results (1701-1710 of 2,116) with videos related to
Sort By:
Pageof 212
Helicobacter|June 20, 2020
The role of Helicobacter pylori in vitamin-B12 deficiency due to metformin useMelih Tansel Gökışık, Seyit UyarHelicobacter|June 18, 2020
Rabeprazole-amoxicillin dual therapy as first-line treatment for H pylori eradication in special patients: A retrospective, real-life studyWen Gao, Hui Ye, Xin Deng, et al.Helicobacter|August 18, 2016
Recent "omics" advances in Helicobacter pyloriElvire Berthenet, Sam Sheppard, Filipa F ValeHelicobacter|August 18, 2016
Pathogenesis of Helicobacter pylori infectionSteffen Backert, Matthias Neddermann, Gunter Maubach, et al.Helicobacter|September 5, 2025
Ten-Day Versus 14-Day Vonoprazan and Amoxicillin Dual Therapy for the Firstline Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled TrialZhiqiang Song, Xiuli Zuo, Zhenyu Zhang, et al.Helicobacter|May 23, 2015
Clinical Features of Community-Acquired Helicobacter cinaedi BacteremiaYoshifumi Uwamino, Kiyoharu Muranaka, Ryota Hase, et al.Helicobacter|August 14, 2021
Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infectionPing-I Hsu, Feng-Woei Tsay, John Y Kao, et al.Helicobacter|February 4, 2023
Impact of body size on efficacy of high-dose dual therapy for Helicobacter pylori eradicationJia-Lun Guan, Ying-Ying Han, Mu-Ru Wang, et al.Helicobacter|December 22, 1999
Effect of cagA status on the sensitivity of enzyme immunoassay in diagnosing Helicobacter pylori-infected childrenM Plebani, G Guariso, P Fogar, et al.Helicobacter|December 22, 1999
Clinical and pathological importance of cagA-positive Helicobacter pylori strains in children with abdominal complaintsM Korzon, G Sikorska-Wiśniewska, Z Jankowski, et al.Pageof 212